Events are the perfect place to network and to make new deals. I have selected for you the best of the best, the creme of the creme, of the hottest biotech event to attend of 2017!

Biotech event march

BIO-Europe Spring

What: BIO-Europe Spring is one of the two BIO-Europe events taking place during the year. Although a bit smaller than the November event, it still gathers several thousand high-level visitors from biotech, pharma and finance for three days of high-caliber networking. 

When: March 20th-22th

Where: Barcelona, ES

Last but not least: BIO-Europe Spring is the perfect place for partnering, as the software platform makes it super easy to meet a lot of new business partners. Also good occasion to go visit Barcelona and grab a Mojito.

Meetup by Labiotech ( yes it’s the ½) 

What: Labiotech.eu is launching its first Meetup in Munich, with many to follow. Great networking opportunity, let’s gather after work around 2 speakers and a beer.

When: April 3rd

Where: Munich, DE

Want to Join? If you around the Munich area and want to attended send us an email at maxime@labiotech.eu to receive your invitation.

SynBioBeta

What: SynBioBeta will bring together leaders and entrepreneurs from multiple facets of the synthetic biology industry. SynBioBeta’s goal is to unite attendees through thought-provoking talks, panels and networking opportunities, allowing the science and business sides of the industry to make critical connections.

When: April  4th-6th

Where: London, UK

Sneak Peek: Advancements in Metabolic Engineering for Synthetic Biology, Designer Biomaterials,Engineering Environmental Sustainability in the Circular Economy and many more…

BioTrinity

What: BioTrinity offers unique access to global life science investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.

When: May 8th-10th

Where: London, UK

Slogan: Build, Discover and Catalyse.

Bio€quity Europe

What: Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community, business development and licensing professionals to do business with independently-selected presenting companies.

When: May 22th-23rd

Where: Paris, FR

Still need convincing?: Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals.

Labiotech Refresh

What: Labiotech Refresh is Europe’s most refreshing biotech event, and the third edition of Refresh will take place in Berlin on June 8th! Come for deep insight into tomorrow’s biotech trends in a dynamic and contemporary setting, and meet with 350 of Europe’s biotech leaders, innovators and enthusiasts.

Where: Berlin, DE

When: Jun, 8th

Memory Refresher: Last edition was a big success, and we can’t wait to do it again! I overheard that the team is as professional as it is cool.

SACHS Basel

What: The 17th Sachs Basel event is another great event when it comes to investing and partnering in the biotech and life science industry. The forum draws together an exciting cross-section of early-stage, pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives.

When: September 26th-27th

Where: Basel, CH

Therapeutic Panels: Advances in Cell & Gene Therapies, Autoimmune & Inflammatory Diseases, Autoimmune & Inflammatory Diseases and more…

CPhi worldwide

What: CPhi worldwide is one of the largest pharma conferences in Europe that enables attendees to find and connect with specific companies tailored to their business needs. It provides the initial platform to spark innovations, bringing pharma suppliers together to meet and develop new dynamic approaches to industry challenges.

When: October 24th-26th

Where: Frankfurt, DE

Good reviews: The pharmaceutical ingredients, outsourcing, packaging and machinery sectors continue to grow apace and CPhi attendees are hugely positive about industry and new business prospects. This event is very pharma-focused but could also be a good opportunity for later-stage biotechs.

BIO-Europe

What: BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. It’s the place to be to find new business partners.

When: November 6th-8th

Where: Berlin, DE

Higlighting the “get-together”: the conference annually attracts leading dealmakers from around the world in biotech, pharma and finance, along with the most exciting emerging companies.

BioFIT

What: BioFit, with the highest attending rate of academics, TTOs and research institutes, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies

When: November 28th-29th

Where: Strasbourg, FR

What to expect: Start-up slams 

Genesis

What: Genesis is London’s premier Life Science & Healthcare conference, taking innovation in biotech to a global market. The event will engage all the key elements for those active in R&D, finance, policy making and service provision across life sciences, digital and health technology fields to visualise the sector’s direction.

When: December 14th

Where: London, UK

What to expect: Genesis 2017 is a great place to meet with the UK Biotech ecosystem and hear the last updates.


Many more events are taking place along 2017, so we invite you to have a look at our events calendar to find out more about them.

This year seems like a rich conference year for Europe with so many fresh conferences like Labiotech Refresh 😉

Which one(s) will you visit? Any other good events on your agenda? Let us know!

ADVERTISEMENT
Previous post

Biosimilars set to take on Oncology after a new Market Authorization

Next post

In the Age of Biological Therapeutics, Chemists move to ADCs